Free Trial

Graphene Investments SAS Purchases 44,600 Shares of UiPath, Inc. (NYSE:PATH)

UiPath logo with Computer and Technology background

Graphene Investments SAS lifted its position in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 21.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 248,100 shares of the company's stock after purchasing an additional 44,600 shares during the period. Graphene Investments SAS's holdings in UiPath were worth $2,555,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in UiPath by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 46,664,124 shares of the company's stock worth $593,101,000 after purchasing an additional 576,458 shares during the period. Senvest Management LLC lifted its stake in shares of UiPath by 29.2% during the 4th quarter. Senvest Management LLC now owns 14,074,783 shares of the company's stock worth $178,890,000 after buying an additional 3,180,300 shares during the last quarter. AQR Capital Management LLC boosted its holdings in shares of UiPath by 45.3% during the 4th quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company's stock worth $84,209,000 after buying an additional 2,072,089 shares during the period. Norges Bank acquired a new position in UiPath in the 4th quarter valued at about $71,191,000. Finally, Jacobs Levy Equity Management Inc. grew its stake in UiPath by 35.6% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company's stock valued at $69,385,000 after buying an additional 1,432,569 shares during the last quarter. 62.50% of the stock is owned by institutional investors.

Insider Transactions at UiPath

In other UiPath news, CEO Daniel Dines sold 45,000 shares of the business's stock in a transaction on Wednesday, June 25th. The shares were sold at an average price of $12.55, for a total transaction of $564,750.00. Following the sale, the chief executive officer now owns 5,688,376 shares of the company's stock, valued at approximately $71,389,118.80. The trade was a 0.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Ashim Gupta sold 98,795 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $12.01, for a total value of $1,186,527.95. Following the completion of the transaction, the chief financial officer now owns 987,322 shares of the company's stock, valued at $11,857,737.22. The trade was a 9.10% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 201,295 shares of company stock valued at $2,423,153. 23.19% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PATH. Canaccord Genuity Group set a $16.00 price objective on UiPath and gave the stock a "buy" rating in a report on Monday, June 2nd. Evercore ISI lifted their price target on UiPath from $11.00 to $15.00 and gave the stock an "in-line" rating in a report on Friday, May 30th. Mizuho decreased their price objective on UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Barclays reissued an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Finally, Royal Bank Of Canada boosted their target price on shares of UiPath from $13.00 to $15.00 and gave the company a "sector perform" rating in a research report on Friday, May 30th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $13.83.

Check Out Our Latest Research Report on PATH

UiPath Trading Up 2.5%

Shares of NYSE:PATH opened at $12.79 on Friday. The firm has a 50 day moving average of $12.35 and a 200-day moving average of $12.53. UiPath, Inc. has a 12 month low of $9.38 and a 12 month high of $15.93. The stock has a market capitalization of $6.84 billion, a PE ratio of -106.53, a PEG ratio of 16.34 and a beta of 1.06.

UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. The business had revenue of $356.62 million for the quarter, compared to analysts' expectations of $332.17 million. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the firm posted $0.13 earnings per share. On average, research analysts predict that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH - Free Report).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double
The Next Palantir? AI-Defense Stock Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines